3 completed, 2 terminated, 1 recruiting, 1 unknown. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 3, Terminated 2, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Recurrent Rectal Cancer: new trials by email Literature Review of Recurrent Rectal Cancer trials Research Report on Recurrent Rectal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Induction Chemotherapy for Locally Recurrent Rectal Cancer Combination drug, Chemoradiotherapy, Surgery locally recurrent rectal cancer - Recurrent Rectal Cancer | Phase 3 | Recruiting | Catharina Ziekenhuis Eindhoven | 364 | 2020-11-13 | 2022-09-06 |
| SGM-101 in Locally Advanced and Recurrent Rectal Cancer SGM-101 - Rectal Cancer, Recurrent Rectal Cancer | Phase 2 / Phase 3 | Unknown | Leiden University Medical Center | 203 | 2019-10-22 | 2020-11-24 |
| Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy irinotecan hydrochloride, leucovorin calcium, fluorouracil - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 3 | Terminated | National Cancer Institute (NCI) | 72 | 2007-06-01 | 2014-07-31 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer oxaliplatin, leucovorin calcium, capecitabine - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 3 | Terminated | National Cancer Institute (NCI) | 2200 | 2004-04-01 | 2013-01-25 |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated bevacizumab, oxaliplatin, leucovorin calcium - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 3 | Completed | National Cancer Institute (NCI) | 880 | 2001-09-01 | 2013-01-24 |
| Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer irinotecan hydrochloride, oxaliplatin, leucovorin calcium - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 3 | Completed | National Cancer Institute (NCI) | 560 | 1999-11-01 | 2013-05-03 |
| Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer fluorouracil, eniluracil - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 3 | Completed | National Cancer Institute (NCI) | 950 | 1999-04-01 | 2013-01-24 |
Rectal Neoplasms (7) · Colonic Neoplasms (5) · Margins of Excision (1)
Colorectal Neoplasms (7) · Digestive System Diseases (7) · Digestive System Neoplasms (7) · Gastrointestinal Diseases (7) · Gastrointestinal Neoplasms (7) · Intestinal Diseases (7) · Intestinal Neoplasms (7) · Neoplasms (7) · Neoplasms by Site (7) · Rectal Diseases (7) · Colonic Diseases (5) · Morphological and Microscopic Findings (1) · Pathological Conditions, Signs and Symptoms (1)
Fluorouracil (5) · Leucovorin (4) · Bevacizumab (3) · Oxaliplatin (3) · Irinotecan (2) · Capecitabine (1) · Cetuximab (1) · Chemoradiotherapy (1) · Drug Combinations (1) · Folfox protocol (1) · IFL protocol (1) · eniluracil (1)
National Cancer Institute (NCI) (5) · Catharina Ziekenhuis Eindhoven (1) · Leiden University Medical Center (1)
United States (5) · Netherlands (2) · Belgium (1) · Norway (1) · Portugal (1) · Sweden (1)
Bruce Giantonio (1) · Charles Blanke (1) · Henry Pitot (1) · John Hines (1) · Philip Gold (1) · Pim Burger, MD (1)
U10CA021115 (2), U10CA032102 (2), U10CA025224 (1)